Richard Lowenthal
Fortune : 75 M $ au 31/05/2026
Fortune : 75 M $ au 31/05/2026
Mr. Richard E.
Lowenthal is a Chief Executive Officer & Director at ARS Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at ARS Pharmaceuticals Operations, Inc. He is on the Board of Directors at ARS Pharmaceuticals, Inc. and ARS Pharmaceuticals Operations, Inc. Mr. Lowenthal was previously employed as a President & Chief Executive Officer by MTG Biotherapeutics, Inc., a President by Pacific-Link Regulatory Consulting, a President-Pacific Link Regulatory Consulting by Research, Inc., a VP-Regulatory Affairs & Quality Assurance by Cadence Pharmaceuticals, Inc., a Head-Worldwide Regulatory Affairs & Drug Safety by Maxim Pharmaceuticals, Inc., a VP-Regulatory Affairs & Quality Assurance by AnGes MG, Inc., a Director-Regulatory Affairs & Quality Assurance by Somerset Pharmaceuticals, Inc., a Global Director-Regulatory Affairs by The Janssen Research Foundation, a Chairman by American Association of Pharmaceutical Scientists, a Member-Corporate Council by The National Organization for Rare Disorders, Inc., and a Regulatory Affairs Officer by Vecta Ltd. He also served on the board at Momotaro-Gene, Inc. He received his graduate degree from Florida State University and a graduate degree from the University of San Diego.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 8 225 473 ( 8,28 % ) | 75 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Fondateur | 05/08/2015 |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Fondateur | 01/01/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
MTG Biotherapeutics, Inc.
MTG Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotherapies | Directeur Général | 01/08/2017 |
Momotaro-Gene, Inc.
Momotaro-Gene, Inc. Medical SpecialtiesHealth Technology Develops molecular targeting drugs for cancer treatment | Directeur/Membre du Conseil | 01/08/2017 |
Research, Inc.
Research, Inc. Building ProductsProducer Manufacturing Designs, manufactures & sells heating and associated control systems | Corporate Officer/Principal | 01/08/2015 |
| CADENCE PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/05/2007 |
Maxim Pharmaceuticals, Inc.
Maxim Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs, therapies and vaccines for cancer and infectious diseases | Conseiller Juridique Général | 01/11/2004 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
Research, Inc.
Research, Inc. Building ProductsProducer Manufacturing Designs, manufactures & sells heating and associated control systems | Producer Manufacturing |
Maxim Pharmaceuticals, Inc.
Maxim Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs, therapies and vaccines for cancer and infectious diseases | Health Technology |
AnGes, Inc.
AnGes, Inc. Pharmaceuticals: GenericHealth Technology Manufactures gene pharmaceutical medicines | Health Technology |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego
University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Health Technology |
Somerset Pharmaceuticals, Inc.
Somerset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Health Services |
The Janssen Research Foundation | |
Vecta Ltd.
Vecta Ltd. Medical SpecialtiesHealth Technology Develops products for the gastrointestinal diseases | Health Technology |
Momotaro-Gene, Inc.
Momotaro-Gene, Inc. Medical SpecialtiesHealth Technology Develops molecular targeting drugs for cancer treatment | Health Technology |
MTG Biotherapeutics, Inc.
MTG Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotherapies | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Pacific-Link Regulatory Consulting
Pacific-Link Regulatory Consulting Pharmaceuticals: OtherHealth Technology Provides medicinal product development and consulting services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national